Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Enterprise Value: 2020-2025

Historic Enterprise Value for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to $138.6 million.

  • Molecular Partners Ag's Enterprise Value fell 17.96% to $138.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.3 million, marking a year-over-year decrease of 135.62%. This contributed to the annual value of -$12.3 million for FY2024, which is 82.69% up from last year.
  • Per Molecular Partners Ag's latest filing, its Enterprise Value stood at $138.6 million for Q3 2025, which was down 1.51% from $140.7 million recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Enterprise Value peaked at $689.3 million during Q2 2021, and registered a low of -$73.4 million during Q4 2023.
  • Over the past 3 years, Molecular Partners Ag's median Enterprise Value value was $140.7 million (recorded in 2025), while the average stood at $156.4 million.
  • In the last 5 years, Molecular Partners Ag's Enterprise Value skyrocketed by 369,831.73% in 2021 and then slumped by 109.66% in 2022.
  • Over the past 5 years, Molecular Partners Ag's Enterprise Value (Quarterly) stood at $472.8 million in 2021, then crashed by 109.66% to -$45.6 million in 2022, then slumped by 60.88% to -$73.4 million in 2023, then surged by 82.32% to -$13.0 million in 2024, then dropped by 17.96% to $138.6 million in 2025.
  • Its Enterprise Value stands at $138.6 million for Q3 2025, versus $140.7 million for Q2 2025 and $142.9 million for Q1 2025.